Clinical Predictors of Severity in Pediatric Community-Acquired Pneumonia at Assiut University Children's Hospital
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-5
SponsorAssiut University
About this trial
This study aims to identify the clinical factors that predict the severity of community-acquired pneumonia (CAP) in pediatric patients. Children admitted to Assiut University Children's Hospital with a diagnosis of CAP will be evaluated through clinical examination, vital signs, laboratory investigations, and radiological findings. The study focuses on determining which clinical features are associated with more severe disease, higher need for oxygen therapy, intensive care admission, or complications. Understanding these predictors may help clinicians recognize severe cases earlier and improve patient management and outcomes.
Eligibility criteria
Qualifiers
Children aged 1 month to 5 years.
Children of both sexes
Onset of illness in the community, not more than 48 hours after hospital admission.
Disqualifiers
Children below 1 month, as neonatal pneumonia differs in pathology and management from CAP.
Children with hospital-acquired pneumonia
Known primary or secondary immunodeficiency
Children with chronic respiratory diseases (as cystic fibrosis, bronchiectasis) or congenital lung malformations.
Trial design
Treatments tested in this trial
- Assessment of Pneumonia Severity
Treatment groups
67 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov